Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Tech Today.
Press releases published on August 5, 2025
Rumble and Cumulus Media Announce Joint Strategic Partnership
GlobeNewswire
·
August 5, 2025
Longboat Key, FL, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Rumble (NASDAQ:RUM), the high-growth video-sharing platform and cloud services provider empowering creators and brands, and Cumulus Media (OTCQB: CMLS), one of the largest audio creators and distributors …
Treace Announces Peer-Reviewed Publication of Four-Year Results of the ALIGN3D™ Lapiplasty® Multicenter Prospective Clinical Study
GlobeNewswire
·
August 5, 2025
PONTE VEDRA, Fla., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities, …
Adaptive Biotechnologies Reports Second Quarter 2025 Financial Results
GlobeNewswire
·
August 5, 2025
SEATTLE, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products …
AvePoint to Participate in Upcoming Investor Conferences
GlobeNewswire
·
August 5, 2025
JERSEY CITY, N.J., Aug. 05, 2025 (GLOBE NEWSWIRE) -- AvePoint (Nasdaq: AVPT), the global leader in data security, governance and resilience, today announced that members of the Company’s executive management team will present at the following investor …
Fractyl Health Reports Potent and Durable Two-Year Real-World Outcomes with Revita® Showing Sustained Weight Loss and Improved Glucose Control After a Single Procedure
GlobeNewswire
·
August 5, 2025
Two-year follow-up in Germany Real-World Registry study showed median 9.6% weight loss and 1.6% HbA1c reduction after a single Revita procedure in participants with type 2 diabetes, with no device- or procedure-related serious adverse events to date New …
Journey Medical Corporation to Announce Second Quarter 2025 Financial Results on August 12, 2025
GlobeNewswire
·
August 5, 2025
SCOTTSDALE, Ariz., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical” or the “Company”) (Nasdaq: DERM), a commercial-stage pharmaceutical company that primarily focuses on selling and marketing U.S. Food and Drug …
Mdxhealth Reports Preliminary Second Quarter 2025 Results, Reaches Positive Adjusted EBITDA, and Announces Acquisition of Exosome Diagnostics Business from Bio-Techne
GlobeNewswire
·
August 5, 2025
Mdxhealth Reports Preliminary Second Quarter 2025 Results, Reaches Positive Adjusted EBITDA, and Announces Acquisition of Exosome Diagnostics Business from Bio-Techne Year-over-year Q2 revenues increased by 20% to $26.6 million Adjusted EBITDA …
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
August 5, 2025
SAN DIEGO, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to …
BridgeBio Reports Second Quarter 2025 Financial Results and Business Updates
GlobeNewswire
·
August 5, 2025
- As of August 1, 2025, 3,751 unique patient prescriptions have been written by 1,074 unique prescribers, representing an accelerating launch driven by strong month over month growth in the crucial treatment naïve patient segment - $110.6 million in total …
SIGA Reports Financial Results for Three and Six Months Ended June 30, 2025
GlobeNewswire
·
August 5, 2025
NEW YORK, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Generated Product Revenues of $79 million for the Three Months Ended June 30 Awarded Additional Development Funding of $27 million under the BARDA 19C Contract during the Three Months Ended June 30 Corporate …
Acumen Pharmaceuticals to Report Second Quarter 2025 Financial Results on August 12, 2025
GlobeNewswire
·
August 5, 2025
NEWTON, Mass., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) (“Acumen” or the “Company”), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets toxic soluble amyloid beta oligomers for the …
Day One Reports Second Quarter 2025 Financial Results and Corporate Progress
GlobeNewswire
·
August 5, 2025
OJEMDA™ (tovorafenib) net product revenue of $33.6 million in Q2 2025, a 10% quarter-over-quarter increase OJEMDA full-year 2025 net product revenue expected to be $140 to $150 million Ended the second quarter with $453.1 million in cash, cash equivalents …
Pacira BioSciences Reports Second Quarter 2025 Financial Results
GlobeNewswire
·
August 5, 2025
-- Solid execution across corporate, clinical and commercial initiatives -- -- Several key milestones advance 5x30 path to growth -- -- Conference call today at 4:30 p.m. ET -- BRISBANE, Calif., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. ( …
IMUNON Recaps Highlights from 2025 Second Quarter Financial Results Conference Call
GlobeNewswire
·
August 5, 2025
Investors are reminded that Shareholders of record as of August 7, 2025, will receive a 15% stock dividend payment LAWRENCEVILLE, N.J., Aug. 05, 2025 (GLOBE NEWSWIRE) -- IMUNON, Inc. (Nasdaq: IMNN), a clinical-stage company in Phase 3 development with its …
Red Cat to Host Town Hall Meeting for Investors, Analysts and Members of the Media
GlobeNewswire
·
August 5, 2025
SAN JUAN, Puerto Rico, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Red Cat Holdings, Inc. (Nasdaq: RCAT) (“Red Cat”), a drone technology company integrating robotic hardware and software for military, government, and commercial operations, today announced that it …
Practice AI™ & SmartAdvocate, Integrating for the Future
GlobeNewswire
·
August 5, 2025
WOODLAND HILLS, Calif., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Practice AI™ is excited to announce its integration with one of the legal industry's premier case management systems, SmartAdvocate. This rollout is part of our ongoing mission to remove friction …
Tevogen.AI Expands Collaboration With Databricks and Microsoft to Build the Beta Version of Its PredicTcell™ Model With a Focus on Oncology
GlobeNewswire
·
August 5, 2025
Tevogen.AI to explore external market opportunities as a potential revenue source. Beta version to incorporate oncology targets, enhancing the accuracy and diversity of the PredicTcell model and potentially accelerating cancer immunotherapy development. …
Ovios Unveils Innovative, No-Assembly Furniture Line to Meet Soaring Demand for Smarter Dorm Living
GlobeNewswire
·
August 5, 2025
Los Angeles, CA, Aug. 05, 2025 (GLOBE NEWSWIRE) -- In response to the growing demand for compact, adaptable living solutions, Ovios today announced the launch of a new line of smart furniture designed specifically for students heading back to campus this …
Seagull 1963 Chronograph Reissue Brings China’s First Military Watch to Global Market
GlobeNewswire
·
August 5, 2025
Tianjin, China, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Seagull Watch Group has officially reissued China’s first military chronograph, originally developed under the classified Cold War-era “Project 304.” Known today as the Seagull 1963, this timepiece is …
ZenaTech cierra su séptima adquisición de Drones como un Servicio (DaaS) en Carolina del Norte, expandiendo su presencia en la región sureste de EE.UU. y fortaleciendo sus oportunidades de negocio con el gobierno
GlobeNewswire
·
August 5, 2025
VANCOUVER, Columbia Británica, Aug. 05, 2025 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) (“ZenaTech”), un proveedor de soluciones tecnológicas empresariales especializado en drones con inteligencia artificial (IA), Drones como …